We tested the role of the Drosophila E-cadherin (shotgun gene, shg) in GBS entry ex vivo, and found that specifically knocking it down in the SPG layer, through the GAL4/UAS system40, did not affect GBS brain entry (Fig. 4a). The gene discussed is LGALS4; the disease is Guillain-Barre syndrome.